Texas
Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries
The U.S. Food and Drug Administration has approved a generic version of the world’s only twice-a-year shot to prevent HIV.
Experts say that a promising drug that offers complete protection against HIV and requires only two shots a year isn't getting to enough people.
Discussion (0)
No comments yet. Start the conversation!